Related content

Clinical Relevance of Estrogen Receptor Variants in Breast Cancer

By Wiltschke C.   Fuqua S.A.W.  

Trends in Endocrinology and Metabolism, Vol. 6, Iss. 3, 1995-04 ,pp. : 77-82

Elsevier

Access to resources Recommend Favorite

Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer

By Georgopoulos Neoklis   Adonakis George   Fotopoulos Andreas   Koika Vasiliki   Spinos Nikitas   Saltamavros Alexandros   Keramopoulos Antonios   Koukouras Dimitrios   Decavalas George   Kourounis George  

Gynecological Endocrinology, Vol. 22, Iss. 4, 2006-04 ,pp. : 185-189

Informa Healthcare

Access to resources Recommend Favorite

Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor

By Milewicz T.   Kolodziejczyk J.   Krzysiek J.   Basta A.   Sztefko K.   Kurek S.   Stachura J.   Gregoraszczuk E. L.  

Gynecological Endocrinology, Vol. 16, Iss. 4, 2002-08 ,pp. : 319-329

Informa Healthcare

Access to resources Recommend Favorite

Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy

By Mariani Luciano   Gadducci Angiolo   Vizza Enrico   Tomao Silverio   Vici Patrizia  

Gynecological Endocrinology, Vol. 29, Iss. 1, 2013-01 ,pp. : 25-29

Informa Healthcare

Access to resources Recommend Favorite

Insulin Receptor - What Role in Breast Cancer?

By Papa V.   Costantino A.   Belfiore A.  

Trends in Endocrinology and Metabolism, Vol. 8, Iss. 8, 1997-10 ,pp. : 306-312

Elsevier

Access to resources Recommend Favorite